IL17A and type 2 diabetes mellitus: Moreover, previous research has identified the IL-17 signaling pathway as a shared enriched immunological pathway in schizophrenia and bipolar disorder, alongside their comorbidities, such as Type 2 Diabetes Mellitus (T2DM) (30).